Patents by Inventor Oliver Lawless

Oliver Lawless has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine composition comprising methylated DNA and immunomodulatory motifs
    Patent number: 7884196
    Abstract: The present invention relates generally to compositions and methods using mammalian, dsDNA (Double Stranded Deoxyribonucleic Acid) vaccination for the induction and maintenance of regulator suppressor T cells resulting in suppression of non infectious, and post infectious, inflammatory, allergic, auto-immune, vasculitic, certain degenerative vascular, and graft versus host diseases, with or without the use of IL-10, and with or without the use or TGF?, with or without the use of anti-IL 6 receptor antibody, anti TNF antibody and or Plasmapheresis, IVIG, Corticosteroids, Methotrexate, Bromocriptine, and or vitamin D analogues.
    Type: Grant
    Filed: October 6, 2005
    Date of Patent: February 8, 2011
    Inventor: Oliver Lawless
  • Treatment of inflammatory, non-infectious, autoimmune, vasculitic, degenerative vascular, host-v-graft diseases, Alzheimers disease, and amyloidosis using mammalian, dsDNA vaccination
    Publication number: 20060111316
    Abstract: The present invention relates generally to compositions and methods using mammalian, dsDNA (Double Stranded Deoxyribonucleic Acid) vaccination for the induction and maintenance of regulator suppressor T cells resulting in suppression of non infectious, and post infectious, inflammatory, allergic, auto-immune, vasculitic, certain degenerative vascular, and graft versus host diseases, with or without the use of IL-10, and with or without the use or TGF?, with or without the use of anti-IL 6 receptor antibody, anti TNF antibody and or Plasmapheresis, IVIG, Corticosteroids, Methotrexate, Bromocriptine, and or vitamin D analogues.
    Type: Application
    Filed: October 6, 2005
    Publication date: May 25, 2006
    Inventor: Oliver Lawless
  • Method for defining and treating chemically-induced immune disorders using tumor necrosis factor (TFNalpha), interleukin-1 (lL-1), and interleulin-6R(lL-6R) antagonists
    Publication number: 20060094645
    Abstract: Compositions and methods are disclosed for treating chemically-induced immune disorders. Pharmacological compositions comprising at least one TNF antagonist, at least one IL-1 antagonist, and at least one IL6R antagonist are disclosed.
    Type: Application
    Filed: October 6, 2005
    Publication date: May 4, 2006
    Inventor: Oliver Lawless